title: Strategies to increase drug penetration in solid tumors.
abstract: Despite significant improvement in modalities for treatment of cancer that led to a longer survival period, the death rate of patients with solid tumors has not changed during the last decades. Emerging studies have identified several physical barriers that limit the therapeutic efficacy of cancer therapeutic agents such as monoclonal antibodies, chemotherapeutic agents, anti-tumor immune cells, and gene therapeutics. Most solid tumors are of epithelial origin and, although malignant cells are de-differentiated, they maintain intercellular junctions, a key feature of epithelial cells, both in the primary tumor as well as in metastatic lesions. Furthermore, nests of malignant epithelial tumor cells are shielded by layers of extracellular matrix (ECM) proteins (e.g., collagen, elastin, fibronectin, laminin) whereby tumor vasculature rarely penetrates into the tumor nests. In this chapter, we will review potential strategies to modulate the ECM and epithelial junctions to enhance the intratumoral diffusion and/or to remove physical masking of target receptors on malignant cells. We will focus on peptides that bind to the junction protein desmoglein 2 and trigger intracellular signaling, resulting in the transient opening of intercellular junctions. Intravenous injection of these junction openers increased the efficacy and safety of therapies with monoclonal antibodies, chemotherapeutics, and T cells in mouse tumor models and was safe in non-human primates. Furthermore, we will summarize approaches to transiently degrade ECM proteins or downregulate their expression. Among these approaches is the intratumoral expression of relaxin or decorin after adenovirus- or stem cell-mediated gene transfer. We will provide examples that relaxin-based approaches increase the anti-tumor efficacy of oncolytic viruses, monoclonal antibodies, and T cells.
authors.affiliation: Department of Bioengineering, College of Engineering, Hanyang University , Seoul , South Korea.
authors.forename: Il-Kyu
authors.initials: IK
authors.lastname: Choi
authors.forename: Robert
authors.initials: R
authors.lastname: Strauss
authors.forename: Maximilian
authors.initials: M
authors.lastname: Richter
authors.forename: Chae-Ok
authors.initials: CO
authors.lastname: Yun
authors.forename: André
authors.initials: A
authors.lastname: Lieber
keywords: epithelial junctions; extracellular matrix; junction opener; relaxin; tumor stroma; tumor-associated macrophages
references.citation: Cell. 2009 Nov 25;139(5):891-906
references.pmid: 19931152
references.citation: N Engl J Med. 2009 Sep 3;361(10):947-57
references.pmid: 19692680
references.citation: J Control Release. 2000 Mar 1;65(1-2):271-84
references.pmid: 10699287
references.citation: Nature. 2003 Mar 20;422(6929):322-6
references.pmid: 12646923
references.citation: Dev Cell. 2010 Jun 15;18(6):884-901
references.pmid: 20627072
references.citation: Mol Ther. 2007 Nov;15(11):1982-90
references.pmid: 17653103
references.citation: J Exp Med. 2011 Dec 19;208(13):2641-55
references.pmid: 22124112
references.citation: J Cell Biol. 1997 Feb 10;136(3):729-43
references.pmid: 9024701
references.citation: Nat Med. 2003 Jun;9(6):796-800
references.pmid: 12754503
references.citation: Dev Dyn. 2005 Sep;234(1):132-42
references.pmid: 16010672
references.citation: PLoS One. 2011 Jan 14;6(1):e16186
references.pmid: 21264259
references.citation: Pharmacol Ther. 2006 Oct;112(1):38-56
references.pmid: 16647137
references.citation: Cancer Res. 1996 Mar 1;56(5):964-68
references.pmid: 8640786
references.citation: Cancer Cell. 2012 Dec 11;22(6):709-24
references.pmid: 23201163
references.citation: Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15399-404
references.pmid: 18809907
references.citation: Cancer Res. 2003 Mar 15;63(6):1405-12
references.pmid: 12649206
references.citation: Endocr Rev. 2004 Apr;25(2):205-34
references.pmid: 15082520
references.citation: J Pharmacol Exp Ther. 2005 Dec;315(3):971-9
references.pmid: 16002463
references.citation: Nat Cell Biol. 2000 Feb;2(2):84-9
references.pmid: 10655587
references.citation: Exp Cell Res. 2001 Mar 10;264(1):169-84
references.pmid: 11237532
references.citation: Int J Biochem Cell Biol. 2007;39(12):2153-60
references.pmid: 17825600
references.citation: Int J Cancer. 2009 Sep 15;125(6):1276-84
references.pmid: 19479998
references.citation: Microvasc Res. 2004 May;67(3):231-6
references.pmid: 15121448
references.citation: Clin Cancer Res. 2008 Jun 15;14(12):3933-41
references.pmid: 18559615
references.citation: Nat Rev Cancer. 2004 Nov;4(11):839-49
references.pmid: 15516957
references.citation: J Virol. 2011 Jul;85(13):6390-402
references.pmid: 21525338
references.citation: Annu Rev Pathol. 2006;1:119-50
references.pmid: 18039110
references.citation: Integr Biol (Camb). 2011 Sep;3(9):910-21
references.pmid: 21842067
references.citation: Cancer Res. 2009 Jun 15;69(12):5115-25
references.pmid: 19491256
references.citation: Nucleic Acids Res. 2005 Nov 24;33(20):6566-78
references.pmid: 16314317
references.citation: Cancer Res. 2007 May 1;67(9):4399-407
references.pmid: 17483354
references.citation: J Cell Biol. 1991 Apr;113(1):155-60
references.pmid: 2007620
references.citation: Microvasc Res. 1996 Mar;51(2):260-72
references.pmid: 8778579
references.citation: Cell. 2005 May 6;121(3):335-48
references.pmid: 15882617
references.citation: Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4628-33
references.pmid: 11274375
references.citation: Drug Discov Today. 2006 Sep;11(17-18):812-8
references.pmid: 16935749
references.citation: J Cell Biol. 2012 Nov 12;199(4):699-711
references.pmid: 23128240
references.citation: Mol Hum Reprod. 2002 Sep;8(9):789-96
references.pmid: 12200455
references.citation: Curr Mol Med. 2008 Dec;8(8):784-804
references.pmid: 19075676
references.citation: J Clin Invest. 2009 Jun;119(6):1420-8
references.pmid: 19487818
references.citation: FASEB J. 2007 Mar;21(3):754-65
references.pmid: 17197386
references.citation: Cancer Res. 2007 Jun 1;67(11):5064-6
references.pmid: 17545580
references.citation: Am J Pathol. 1984 Jun;115(3):329-33
references.pmid: 6329001
references.citation: Nat Rev Cancer. 2004 Nov;4(11):891-9
references.pmid: 15516961
references.citation: Cancer Sci. 2012 Apr;103(4):828-35
references.pmid: 22321022
references.citation: Clin Exp Immunol. 2003 Dec;134(3):508-15
references.pmid: 14632759
references.citation: Cell. 2010 Apr 2;141(1):52-67
references.pmid: 20371345
references.citation: Drug Resist Updat. 2008 Aug-Oct;11(4-5):123-51
references.pmid: 18718806
references.citation: Biochem J. 2006 Mar 1;394(Pt 2):449-57
references.pmid: 16232121
references.citation: Cancer Res. 2006 Jul 15;66(14):6919-27
references.pmid: 16849535
references.citation: Exp Cell Res. 2007 Jun 10;313(10):2228-35
references.pmid: 17524395
references.citation: Dev Cell. 2010 Mar 16;18(3):342-56
references.pmid: 20230744
references.citation: FASEB J. 2004 Jun;18(9):1016-8
references.pmid: 15059978
references.citation: Curr Drug Targets. 2007 Jan;8(1):91-104
references.pmid: 17266534
references.citation: Nat Rev Mol Cell Biol. 2002 Mar;3(3):155-66
references.pmid: 11994736
references.citation: Nat Rev Cancer. 2006 May;6(5):392-401
references.pmid: 16572188
references.citation: Nat Rev Cancer. 2004 Oct;4(10):806-13
references.pmid: 15510161
references.citation: J Clin Invest. 2006 Aug;116(8):2132-2141
references.pmid: 16862213
references.citation: J Cell Biol. 1999 Oct 4;147(1):195-204
references.pmid: 10508866
references.citation: Cancer Res. 2001 Jun 15;61(12):4756-60
references.pmid: 11406548
references.citation: Nat Rev Immunol. 2009 Mar;9(3):162-74
references.pmid: 19197294
references.citation: Int J Oncol. 2012 Jun;40(6):1733-47
references.pmid: 22447316
references.citation: Mol Ther. 2004 May;9(5):650-7
references.pmid: 15120325
references.citation: Science. 2002 May 10;296(5570):1046-9
references.pmid: 12004111
references.citation: Pharm Res. 2002 Nov;19(11):1680-8
references.pmid: 12458674
references.citation: World J Gastroenterol. 2012 Mar 21;18(11):1208-15
references.pmid: 22468084
references.citation: Gynecol Oncol. 2004 Jan;92(1):47-56
references.pmid: 14751137
references.citation: Cancer Res. 1991 May 15;51(10):2727-30
references.pmid: 2021951
references.citation: Nature. 2004 Nov 18;432(7015):332-7
references.pmid: 15549095
references.citation: Cancer Res. 2005 Dec 15;65(24):11743-51
references.pmid: 16357187
references.citation: Microvasc Res. 1989 Jan;37(1):77-104
references.pmid: 2646512
references.citation: Cancer Res. 2010 Jul 15;70(14):5728-39
references.pmid: 20570887
references.citation: Mol Cancer Ther. 2010 Dec;9(12):3221-32
references.pmid: 21159608
references.citation: Microvasc Res. 1990 Sep;40(2):246-63
references.pmid: 2250603
references.citation: J Cell Biochem. 2011 Jan;112(1):10-29
references.pmid: 21104905
references.citation: J Cell Sci. 2003 May 15;116(Pt 10):1959-67
references.pmid: 12668723
references.citation: Mol Ther. 2009 Oct;17(10):1724-32
references.pmid: 19602998
references.citation: Biochim Biophys Acta. 1994 May 27;1198(1):11-26
references.pmid: 8199193
references.citation: Br J Cancer. 2008 Jan 29;98(2):245-9
references.pmid: 18182995
references.citation: Methods Mol Med. 2003;86:155-66
references.pmid: 12886767
references.citation: J Pathol. 1998 Nov;186(3):262-8
references.pmid: 10211114
references.citation: Am J Pathol. 2005 Sep;167(3):627-35
references.pmid: 16127144
references.citation: J Natl Cancer Inst. 2006 Oct 18;98(20):1482-93
references.pmid: 17047197
references.citation: Nat Med. 2011 Jan;17(1):96-104
references.pmid: 21151137
references.citation: Cell. 2002 Sep 20;110(6):789-99
references.pmid: 12297051
references.citation: Biochem J. 1984 Nov 1;223(3):587-97
references.pmid: 6439184
references.citation: Dis Model Mech. 2011 Mar;4(2):165-78
references.pmid: 21324931
references.citation: J Control Release. 2001 Jul 6;74(1-3):7-25
references.pmid: 11489479
references.citation: Int J Cancer. 2006 Jan 1;118(1):62-73
references.pmid: 16049981
references.citation: Sci Transl Med. 2013 May 8;5(184):184ra59
references.pmid: 23658244
references.citation: Cancer Res. 2013 Feb 1;73(3):1128-41
references.pmid: 23221383
references.citation: Cancer Sci. 2007 Dec;98(12):2009-18
references.pmid: 17924976
references.citation: Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
references.pmid: 11259830
references.citation: Clin Cancer Res. 2006 Sep 15;12(18):5395-402
references.pmid: 17000672
references.citation: Breast Cancer Res Treat. 2009 Nov;118(1):113-24
references.pmid: 19415485
references.citation: Mol Cell Endocrinol. 2008 Jan 2;280(1-2):30-8
references.pmid: 17961912
references.citation: Gene Ther. 2010 Feb;17(2):190-201
references.pmid: 19907500
references.citation: PLoS One. 2010 Mar 22;5(3):e9808
references.pmid: 20339555
references.citation: Anticancer Res. 2010 Feb;30(2):359-68
references.pmid: 20332440
references.citation: Int J Cancer. 1994 Jan 15;56(2):249-54
references.pmid: 8314308
references.citation: J Cell Sci. 2000 Jul;113 ( Pt 13):2363-74
references.pmid: 10852816
references.citation: J Clin Invest. 1985 Aug;76(2):837-48
references.pmid: 2993365
references.citation: Cell. 2011 Jun 10;145(6):926-40
references.pmid: 21663795
references.citation: J Biol Chem. 2001 Jul 20;276(29):27424-31
references.pmid: 11309385
references.citation: Biotechnol Bioeng. 1999 Mar 5;62(5):562-75
references.pmid: 10099565
references.citation: Exp Cell Res. 2010 May 1;316(8):1324-31
references.pmid: 20211171
references.citation: Adv Drug Deliv Rev. 1997 Jul 7;26(2-3):71-90
references.pmid: 10837535
references.citation: J Pharm Sci. 2000 Apr;89(4):429-42
references.pmid: 10737905
references.citation: Nat Rev Cancer. 2008 Oct;8(10):755-68
references.pmid: 18784658
references.citation: Mol Biol Cell. 2007 Jun;18(6):2013-25
references.pmid: 17392517
references.citation: Am J Cancer Res. 2012;2(5):529-39
references.pmid: 22957305
references.citation: J Pathol. 2005 Oct;207(2):199-206
references.pmid: 16025435
references.citation: Cancer Res. 2006 Jan 15;66(2):605-12
references.pmid: 16423985
references.citation: Clin Cancer Res. 2000 Aug;6(8):3282-9
references.pmid: 10955814
references.citation: Genes Dev. 1991 Sep;5(9):1568-76
references.pmid: 1884999
references.citation: J Cell Sci. 2004 Apr 1;117(Pt 9):1675-85
references.pmid: 15075229
references.citation: Mol Ther. 2011 Mar;19(3):479-89
references.pmid: 21081901
references.citation: Curr Opin Genet Dev. 2009 Feb;19(1):67-73
references.pmid: 19211240
references.citation: Curr Opin Cell Biol. 2010 Oct;22(5):697-706
references.pmid: 20822891
references.citation: Clin Cancer Res. 2001 Oct;7(10):3097-105
references.pmid: 11595701
references.citation: Cancer Res. 1990 Aug 1;50(15):4478-84
references.pmid: 2369726
references.citation: Br J Cancer. 1998 Jun;77(11):1792-8
references.pmid: 9667648
references.citation: Nat Rev Cancer. 2002 Jun;2(6):442-54
references.pmid: 12189386
references.citation: Dev Cell. 2003 Sep;5(3):475-86
references.pmid: 12967566
references.citation: J Clin Oncol. 2009 Oct 1;27(28):4709-17
references.pmid: 19720929
references.citation: J Cell Biol. 2008 Nov 17;183(4):737-49
references.pmid: 19015320
references.citation: Cancer Cell. 2012 Dec 11;22(6):725-36
references.pmid: 23201165
references.citation: Cell Oncol. 2005;27(4):203-13
references.pmid: 16308469
references.citation: J Pharmacol Exp Ther. 1999 Aug;290(2):871-80
references.pmid: 10411604
references.citation: J Virol. 2012 Jun;86(11):6286-302
references.pmid: 22457526
references.citation: Sarcoma. 2011;2011:598218
references.pmid: 21559267
references.citation: Cancer. 1998 Jun 15;82(12):2418-26
references.pmid: 9635535
references.citation: Cancer Res. 2006 Mar 1;66(5):2509-13
references.pmid: 16510565
references.citation: Cell. 2009 Nov 25;139(5):871-90
references.pmid: 19945376
references.citation: Development. 2004 Dec;131(23):5883-95
references.pmid: 15539485
references.citation: Cancer. 1995 Feb 15;75(4):1010-7
references.pmid: 7842402
references.citation: Mol Biol Cell. 2007 Jan;18(1):189-200
references.pmid: 17093058
references.citation: Nature. 2002 Dec 19-26;420(6917):860-7
references.pmid: 12490959
references.citation: Cancer Cell. 2005 Mar;7(3):211-7
references.pmid: 15766659
references.citation: Cancer Metastasis Rev. 1990 Nov;9(3):253-66
references.pmid: 2292138
references.citation: J Immunother. 2012 Apr;35(3):267-75
references.pmid: 22421944
references.citation: PLoS One. 2012;7(3):e33183
references.pmid: 22432005
references.citation: Nat Rev Cancer. 2005 Sep;5(9):744-9
references.pmid: 16148886
references.citation: Physiol Rev. 1996 Jan;76(1):69-125
references.pmid: 8592733
references.citation: Gene Ther. 1998 Feb;5(2):189-95
references.pmid: 9578838
references.citation: Mol Ther. 2008 Oct;16(10):1665-73
references.pmid: 18665155
references.citation: EMBO J. 2003 May 15;22(10):2453-62
references.pmid: 12743039
references.citation: J Clin Invest. 2002 Nov;110(10):1525-38
references.pmid: 12438450
references.citation: Cancer Res. 2007 Mar 15;67(6):2729-35
references.pmid: 17363594
references.citation: J Exp Biol. 2007 Aug;210(Pt 15):2754-64
references.pmid: 17644690
references.citation: Science. 2013 Feb 1;339(6119):580-4
references.pmid: 23372014
references.citation: J Cell Biochem. 2007 Jul 1;101(4):805-15
references.pmid: 17226777
references.citation: Nature. 2004 Feb 19;427(6976):695
references.pmid: 14973470
references.citation: Clin Cancer Res. 2012 Aug 15;18(16):4266-76
references.pmid: 22896693
references.citation: J Cell Biol. 2005 Dec 19;171(6):939-45
references.pmid: 16365161
references.citation: Nature. 1990 Jul 19;346(6281):281-4
references.pmid: 2374594
references.citation: Cancer Res. 2011 Nov 15;71(22):7080-90
references.pmid: 21990319
references.citation: Br J Cancer. 1997;75(9):1247-55
references.pmid: 9155042
references.citation: Bioconjug Chem. 2010 Jul 21;21(7):1264-70
references.pmid: 20536171
references.citation: Med Res Rev. 2014 Jan;34(1):77-105
references.pmid: 23401142
references.citation: Cancer Res. 2002 Dec 1;62(23):6891-900
references.pmid: 12460904
references.citation: Nat Rev Immunol. 2006 Apr;6(4):295-307
references.pmid: 16557261
references.citation: Cancer Res. 2002 Dec 1;62(23):7042-9
references.pmid: 12460925
references.citation: Cell. 2004 Jun 25;117(7):927-39
references.pmid: 15210113
references.citation: Curr Opin Mol Ther. 2008 Aug;10(4):356-61
references.pmid: 18683100
references.citation: Chem Biol. 1996 Nov;3(11):895-904
references.pmid: 8939708
references.citation: EMBO J. 2004 Apr 21;23(8):1739-48
references.pmid: 15057284
references.citation: Breast Cancer Res. 2008;10(4):R71
references.pmid: 18718015
references.citation: Genes Dev. 1994 Apr 15;8(8):970-80
references.pmid: 7926781
references.citation: Am J Pathol. 1998 Jan;152(1):83-92
references.pmid: 9422526
references.citation: Gene Ther. 1999 Sep;6(9):1520-35
references.pmid: 10490761
references.citation: Mol Biol Cell. 2005 Jan;16(1):14-23
references.pmid: 15509650
references.citation: J Cell Sci. 2005 Sep 15;118(Pt 18):4283-93
references.pmid: 16141229
references.citation: J Cell Sci. 2004 May 15;117(Pt 12):2435-47
references.pmid: 15159449
references.citation: Oncogene. 2014 Apr 3;33(14):1743-54
references.pmid: 23604130
references.citation: Nat Rev Cancer. 2001 Oct;1(1):46-54
references.pmid: 11900251
references.citation: Nat Rev Cancer. 2004 Jan;4(1):71-8
references.pmid: 14708027
references.citation: BMC Cancer. 2012 Jan 24;12:35
references.pmid: 22273460
references.citation: Dev Cell. 2009 Oct;17(4):482-93
references.pmid: 19853562
references.citation: Mol Biol Cell. 2007 Nov;18(11):4565-78
references.pmid: 17804817
references.citation: Br J Cancer. 2006 Aug 7;95(3):272-81
references.pmid: 16832418
references.citation: Nat Immunol. 2010 Oct;11(10):889-96
references.pmid: 20856220
references.citation: Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10356-61
references.pmid: 11526241
references.citation: Br J Cancer. 2004 Jun 1;90(11):2053-8
references.pmid: 15164120
references.citation: Cancer Treat Res. 2002;107:161-83
references.pmid: 11775449
references.citation: Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5242-6
references.pmid: 2052603
references.citation: Oncogene. 2003 May 19;22(20):3162-71
references.pmid: 12789292
references.citation: Cell Host Microbe. 2007 Sep 13;2(3):181-92
references.pmid: 18005733
references.citation: Annu Rev Physiol. 1998;60:143-59
references.pmid: 9558458
references.citation: Blood. 2009 May 28;113(22):5423-33
references.pmid: 19329780
references.citation: Acta Derm Venereol. 1996 Nov;76(6):417-20
references.pmid: 8982400
references.citation: J Pathol. 2003 Jul;200(4):500-3
references.pmid: 12845617
references.citation: Nature. 2011 Nov 02;480(7378):530-3
references.pmid: 22048310
references.citation: Clin Cancer Res. 2012 Jun 15;18(12):3340-51
references.pmid: 22535153
references.citation: J Cell Biol. 2012 Feb 20;196(4):395-406
references.pmid: 22351925
references.citation: J Cell Biol. 1993 Dec;123(6 Pt 2):1777-88
references.pmid: 8276896
references.citation: BMC Cancer. 2010 Jun 03;10:255
references.pmid: 20525277
references.citation: Cancer Res. 2000 May 1;60(9):2497-503
references.pmid: 10811131
references.citation: Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15191-6
references.pmid: 11734628
references.citation: Cancer Res. 2006 Sep 1;66(17):8319-26
references.pmid: 16951136
references.citation: Cancer Res. 2007 Nov 15;67(22):10664-8
references.pmid: 18006807
references.citation: Science. 2002 May 31;296(5573):1644-6
references.pmid: 12040179
references.citation: Hum Gene Ther. 2000 Nov 1;11(16):2219-30
references.pmid: 11084679
references.citation: J Cell Sci. 2006 Jan 1;119(Pt 1):66-74
references.pmid: 16371651